You have 9 free searches left this month | for more free features.

rociletinib

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced or Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Rociletinib)

Terminated
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer
  • Rociletinib
  • Duarte, California
  • +48 more
Jul 26, 2020

NSCLC Trial in Santa Monica (Rociletinib, MPDL3280A)

Terminated
  • Non-small Cell Lung Cancer
  • Santa Monica, California
    University of California at Los Angeles
Jun 28, 2019

NSCLC Trial in Worldwide (Rociletinib)

Terminated
  • Non-small Cell Lung Cancer
  • Rociletinib
  • Alhambra, California
  • +90 more
Jul 28, 2020

NSCLC Trial in United States (Rociletinib, Trametinib)

Terminated
  • Non-small Cell Lung Cancer
  • Saint Louis, Missouri
  • +3 more
Sep 28, 2018

NSCLC Trial in United States (Rociletinib)

No longer available
  • Non-small Cell Lung Cancer
  • Rociletinib
  • Scottsdale, Arizona
  • +10 more
Sep 24, 2018

NSCLC Trial in Worldwide (Rociletinib, Pemetrexed or gemcitabine or paclitaxel or docetaxel)

Terminated
  • Non-small Cell Lung Cancer
  • Rociletinib
  • Pemetrexed or gemcitabine or paclitaxel or docetaxel
  • Bakersfield, California
  • +79 more
Jul 31, 2019

NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial (Rociletinib, Biopsy, Blood draw)

Withdrawn
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Rociletinib
  • +2 more
  • (no location specified)
May 16, 2016